Reversed-phase high performance liquid chromatography as an alternative to animal bioassay for human thyrotropin potency determination
- 11 July 2014
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 6 (17) , 6688-6694
Abstract
Reversed-phase high performance liquid chromatography (RP-HPLC) was compared to the in vivo bioassay (BA) based on TSH-induced T4 determination in mice. A linear relationship (BAμg = 0.9790 RP-HPLCμg − 0.052) with a highly significant correlation (r = 0.87; p < 0.001; n = 14 preparations) was found between these two methods. The mean difference between the bioactivity predicted from RP-HPLC data via this equation and the mean of the bioactivities obtained with the two methods for 11 other hTSH preparations was −2.01%, with a 95% confidence interval of −13.13% to +9.11%. This analysis included 5 totally or partially-degraded samples, indicating a useful correlation between the two determinations and, as expected, a higher sensitivity of the physical–chemical method. Interestingly, a commercial hTSH lot did not show any alteration 2 years post expiration date. These results demonstrate that RP-HPLC is a novel and viable alternative to the use of in vivo bioassays for hTSH potency determination, thus avoiding or reducing animal use.Keywords
This publication has 29 references indexed in Scilit:
- Stability of Recombinant Human Thyrotropin Potency Based on Bioassay in FRTL-5 CellsThyroid®, 2010
- Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer managementCurrent Opinion in Oncology, 2010
- CZE for glycoform profiling and quality assessment of recombinant human interleukin‐7Electrophoresis, 2009
- Efficient isolation of the subunits of recombinant and pituitary glycoprotein hormonesJournal of Chromatography A, 2009
- Practical reversed-phase high-performance liquid chromatography method for laboratory-scale purification of recombinant human thyrotropinJournal of Chromatography A, 2007
- The Effect of Posttranslational Modifications on the In Vitro Activity of Recombinant Human Thyroid-Stimulating HormoneThyroid®, 2003
- Prediction of the In-vivo Biological Activity of HumanRecombinant Follicle-stimulating Hormone Using Quantitative Isoelectric Focusing. Optimization of the ModelPharmacy and Pharmacology Communications, 1999
- Prediction of thein vivoBiological Activity of Human Recombinant Follicle Stimulating Hormone Using Quantitative Isoelectric FocusingBiologicals, 1997
- A Novel, Nonradioactive in Vivo Bioassay of Thyrotropin (TSH)Thyroid®, 1995
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986